Karin Schelch

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 3

Top Topics

Brain Metastases

Chronic Lymphocytic Leukemia

Long Noncoding Rna

Top Venues

British journal of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Zsuzsanna Valko, Zsolt Megyesfalvi, Anna Schwendenwein, Christian Lang, Sandor Paku, Nandor Barany, Bence Ferencz, Anita Horvath-Rozsas, Ildiko Kovacs, Erzsebet Schlegl, Veronika Pozonec, Kristiina Boettiger, Melinda Rezeli, Gyorgy Marko-Varga, Ferenc Renyi-Vamos, Mir Alireza Hoda, Thomas Klikovits, Konrad Hoetzenecker, Michael Grusch, Viktoria Laszlo, Balázs Dome, Karin Schelch
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer. British journal of cancer (2023)
Anna Solta, Kristiina Boettiger, Ildikó Kovács, Christian Lang, Zsolt Megyesfalvi, Franziska Ferk, Miroslav Mišík, Konrad Hötzenecker, Clemens Aigner, Christian R Kowol, Siegfried Knasmueller, Michael Grusch, Beáta Szeitz, Melinda Rezeli, Balázs Dome, Karin Schelch
Entinostat enhances the efficacy of chemotherapy in small cell lung cancer through S-phase arrest and decreased base excision repair. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Karin Schelch, Michaela B Kirschner, Marissa Williams, Yuen Y Cheng, Nico van Zandwijk, Michael Grusch, Glen Reid
A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma. Molecular oncology 12 (1) (2017)